Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

ANAT 381 > Ryan Lecture 6 > Flashcards

Ryan Lecture 6 Flashcards

1
Q

Name and describe the regions of a limb from proximal to distal

A

Stylopod = humerus
Zeugopod = ulna, radius
Autopod = carpals, digits
= blocks of tissue to form continuous structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name and describe 3 critical regions in developing limb bud

A

Progress zone
Zone of polarizing activity ZPA
Apical ectodermal ridge = AER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe AER

A

REGION of thickened ectoderm
Forms at boundary between dorsal and ventral sides limb bud
Required for patterning all 3 axes of limb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

WHAT IS required for PD axis

A

AER
Removing AER = inhibits proximal distal growth of limb bud
Progress zone wont grow or do mitosis = wont form structures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Ffg8 expression in AER

A

Specific patterned expression = thickened region ectoderm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can replace AER activity

A

Fgf bead
If remove AER but implant fgf bead = normal wing develops, gets outgrowth
Bead replaces patterning signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe gradient along limb P-D axis

A

opposing RA-FGF gradients
Proximal = retinoic acid
Distal = fgfs/wnts
Threshold patterns= retinoic acid —> fgf = stylopod meis, Zeugopod hox11, autopod hox13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe hox expression along trunk A-P axis and limb P-D axis

A

Homeotic selector genes
Come on later in dev - for limbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe HOX expression along Limb P-D axis

A

Domains of expression correspond to subdomains of limb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe experiment to test RA effects on limb bud P-D patterning

A

Limb bud tips transplanted to bead region of embryo - tips, distal ends of progress zone
Limb bud tips were either transplanted directly or first treated with RA
Staging = number of somites present
Untreated = see distal structures of autopod
Ra treated = in early see more proximal structures, bones they form, but tissues less competent to respond at later dev
Explanation = effect of age of limb bud tip, effect of RA, older and more distal to RA signal = less likely to be responsive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe experiments to test how FGF/wnt effects on limb bud P-D patterning

A

Untreated stage 18 mesenchyme
Stage 18 mesenchyme incubated with fgf/wnt
= see less meis1 fgf repressing proximal gene expression
Not much effect in Zeugopod, hoxa10
In autopod = maybe enhancing, hoxa13
Opposite effects = suggests gradients opposing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What causes mice to miss Zeugopod

A

Hoxa11/Hoxd11 deficient mice
Loses whole structure if do not have tissue to pattern them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What casues polysyndactayly in humans - fused digits

A

Homozygous mutation in HOXD13
Autopod region
Lost patterning of mesenchyme, maybe loss of webbing early on
= misshaped did his but dorsal ventral axis fine (can see finger nails)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does AER activity require

A

Limb bud mesenchyme
Replace limb bud mesenchyme with non limb mesenchyme = from diff part embryo
AER regresses = limbs dev stops, doesn’t support maintained of AER and low levels fgf8
Indicates that patterning molecules also exist in limb bud mesenchyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is P-D specification of limb correlated with

A

Age of progression zone mesenchyme
Young progression zone into old limb buds = still grow, duplicate Zeugopod and stylopod
Old progression zone onto young limb buds = lost midsection,retains info and dominates how it develops = lose most of stylopod and Zeugopod

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where does AER form

A

AT BOUDNARY OF DORSAL AND VENTRAL ECTODERM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does AER FORM

A

Pushes out and get out pouching ectoderm
Turns around it
Dorsal = lmx1
Ventral = en-1
AER acts like local organizer = becomes limb bud
, also get patterning info in msenchyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

WHAT IS expressed in dorsal domains in limb bud

A

Wnt7a expressed in dorsal ectoderm
Lmx1 - lim1 expressed in dorsal mesoderm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is expressed in ventral domains of limb bud

A

En-1 (engrailed) expressed in ventral ectoderm
BOUDNARY where engrailed Meets wnt7 = fgf turns on in AER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe D-V patterning pathway in limb bud

A

OPPOSE each other = keep d and v separate and keep ridge AER
Dorsal = Wnt7a, lmx1b
Ventral = en1, bmp
En1 inhibits r-fng (—>AER formation) and Wnt7a (—> lmx1—>dorsal pattern)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe Dorsal-ventral patterning by Wnt7a

A

Lmx1b dependent dorsal ventral patterning by Wnt7a
Foot pad=ventral
If lmx1 mutant = remove form dorsal mesoderm = lose dorsal structures on dorsal and ventral =footpads

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What happens when engrailed KO

A

Loss of ventral patterning in limb
Ventral missing so dorsal no longer repressed so takes on dorsal phenotype
Nail replaces food pad
Repress other one so drives ventral and prevents dorsal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What can AER also do

A

Pattern a-p axis
Addition of AER tissue cases digit duplication
Has ability to pattern and duplicate But not so much overall polarizing region
In autopod region, depends on time too
Same orientation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe ZPA

A

Not morphologically visible
Located in posterior margin fo limb bud
Found via transplantation exp then molecularly
Post = shh concentrated in ZPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe ZPA transplantation experiments

A

Front post to anterior = 2 zpa, transplant one
Now = digits face each other - mirror image
Change in dose shh patterns digits
Mouse zpa to chick also works - source does not matter, digits look like chick digits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Where is Shh expressed

A

In ZPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What can replace ZPA activity

A

Shh
Transplantation exp = transplanting zpa or shh beads causes mirror image duplication - different from digit duplicated caused by transplanting AER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe how digit 1 response to shh signalling

A

Thumb, shh independent
Further away from zpa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Describe how digits 2 and. 3 respond to shh signaling

A

Differentiation dependent on shh concentration - paracrine signalling
Lower dose but still need it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Describe how digits 4 and 5 response to shh signaling

A

Shh dependent, time dependent - auto rise
Highest exposure, most dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Describe signalling from ZPA

A

Dose dependent
Long range
ZPA MUST be in contact with AER = feedback loop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Describe timing of expression of fgf8 and shh

A

Fgf8 expressed in AER before shh expressed in zpa
Aeschylus stage = formation 3 somites, = stage 16, so 4.5 hrs
Shh= comes on aprox 12 hrs after fgf8 in AER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What regulates outgrowth of progress zone

A

Feedback loops between AER and limb mesenchyme regulate outgrowth of the progress zone
Fgf8 = + effect on shh in ZPA, also inhibits gremlin =antagonist bmp
Complicated feedback between AER ad zpa, and molecules expressed in limb bud mesenchyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Describe feedback loops between AER AND LIMB MESENCHYME

A

Low fgf = turns on shh —> grem1 (repress bmps)
Then HIGH fgf = represses grem1 so bmps increases and
Goes back to low fgf, repeat
Control timing and level of expression = gives differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What determines limb identity

A

Position of fgf bead
Along a-p flank
Limb mesenchyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What can change identity of limb

A

Replacing forelimb mesenchyme with hindlimb mesenchyme changes identity of limb
Cells contain patterning info = how we shape bones or how muscle attaches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Describe what is specific to forelimb or hindlimb bud

A

Tbx5 = in wing bud uniquely
Tbx4 = hind limb bud
Pitx1 = hind limb bud, close relative of pitx2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Describe Tbx5 and tbx4 expression in ectopic limb buds

A

Also pressed in other regions
Tbx5 = top half expresses,
Tbx4 =bottom, not top, like post limb bud
GIVES CHIMERA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What do Tbx5 knockout mice tell us = EARLY KO

A

Forelimbs do not Develop
Express recombinase in this region of limb - prx1cre, Tbx5 lox/lox

40
Q

What do Tbx5 knockout mice tell us = LATER KO

A

Delete only after E9.5 = forelimbs patterned normally
Treat at diff days, some delay for effect tho
After limb buds already formed
Earlier knockout = much severe phenotype

41
Q

What do Tbx5 knockout mice tell us =DESCRIBE EXP METHOD

A

Tbx flaked by lox sides
Cre recombinase clips lox site and repair so tissue specific knockout
Tbx5 flanked by loxP sites
Cre recombinase cuts dna at loxP sites
Expression of Cre is driven by prx1 promoter..limb specific, drives expression for limb protein
Cre fused to estrogen receptor (piece of) ligand binding domain, so only enters nucleus when estrogen ligand present, acts as tf
Introduce estrogen by gavaging pregnant moms at different days, via tamoxifen and will delect tbx5

42
Q

DESCRIBE Exp where early ko Tbx5 and then express tbx4 or pitx1 in forelimb

A

If add ectopic tbx4 in forelimb bud = can rescue forelimb
If add ectopic pitx1 in forelimb bud = cannot compensate,cannot rescue
Tbx4 and tbx5 activate same set of target genes in developing limb bud
Date suggests that tbx4/5 required for fore/hind limb bud initiation but not identity

43
Q

Describe exp = ectopic misexpression of pitx1 in wing bud

A

Retrovirus expression pitx1 is injected into flank at position of forelimb bud
=cause it to have more hindlimb identity, more important for hindlimb identity
Suggest = pitx1 dominantly drives expression of genes needed to give you hind limb identity

44
Q

Describe species specific patterning of limb bud

A

Same set of genes needed for initiating patterning
Species specific events layered on top

45
Q

Describe disrupting embryonic dev

A

2 haploid cells, genes and environment = lead to 1 trillion diploid cells + some haploid cells, germ cells

46
Q

How often are babies born with birth defects

A

Every 4.5 mins there is a baby born in the US with a birth defect

47
Q

What is leading cause of infant mortality

A

Birth defects
1 in 5 infant deaths due to birth defect - 2006 (in first 2 years life)
Among top 5 causes of death between 2 and 18 y/o

48
Q

Describe some estimated stats for embryos

A

20-50% of human cleavage stage embryos implant
40% of embryos that implant survive to term
2.5% live births have a recognizable birth defect, could be minor or severe

49
Q

What accounts for neonatal death

A

Congenital abnormalities account for ~9% of annual neonatal deaths
Preterm birth is a direct cause of 35% of all neonatal deaths
Cost = huge if severe birth defect

50
Q

Describe embryo vs fetus = EMBRYO

A

Period of dev during which organism does not resemble adult
First 8 weeks in humans
All major organ systems established

51
Q

Describe embryo vs fetus = FETUS

A

Period of dev where organism resembles adult
Weeks 9-40 in humans
Growth and refinement = cells differentiation

52
Q

WHEN IS risk of defects highest

A

Organogenesis
3 weeks before gastrulation = wont notice but die
Formation of organs= period of max sensitivity to abnormal dev - 2-8 weeks, heart defects, spina bifida
Growth and maturation of organ systems = 8-38 weeks, affect differentiation of systems, fetal development

53
Q

Describe critical times in prenatal development

A

Major congenital abnormalites
Highly sensitive period bc that is when they develop
Death of embryo and spontaneous abortion common during weeks 1-2 = periof of dividing zygote, implantation, bilaminar embryo

54
Q

Describe period of sensitivity during dev

A

Heart = weeks 3.5 to 9
Eyes = weeks 4.5 to full term
Cns =weeks 3 to full term
Ears = 4.25 to 20
Teeth = 6.75 to full term
Palate = weeks 6.75 to 16
Upper limbs = 4.5 to 9
External genitalia = weeks 7 to full term
Lower limbs = weeks 4.5 to 9

55
Q

Describe genetic heterogeneity

A

Similar phenotypes casues by diff genes/pathways
Mutations

56
Q

Describe phenotypic heterogeneity

A

Same mutation cases diff phenotypes in diff people
One gene among many - also second hit
Also environment = mother gets disease of malnourished = can affect embryo, Matt ion makes embryo more susceptible

57
Q

Name causes of congenital anomalies/birth defects

A

Genetic factors
Environmental factors
Stochastic
Most =dont know

58
Q

Describe causes of congenital anomalies/birth defects = genetic factors

A

Chromosomal - numerical and structural
Gene mutations

59
Q

Describe causes of congenital anomalies/birth defects = environmental factors

A

Teratogens - disruptions
Physical environment = deformations

60
Q

Describe causes of congenital anomalies/birth defects = stochastic

A

Wild type genes, favourable environment
+ bad luck
Protein synthesis fluctuations
Random and cause differences

61
Q

Name 4 structural changes in dev

A

Dysplasia
Deformations
Malformations
Disruptions

62
Q

Describe dysplasia - structural changes in dev

A

Abnormal organizer of cells into tissues and its morphological result
Abnormal growth mostly benign

63
Q

Describe deformations - structural changes in dev

A

Caused by mechanical forces = psychical environment, disrupt how formed

64
Q

Describe malformations - structural changes in dev

A

Genes
Caused by intrinsically abnormal developmental process
Abnormal form beginning
Defect of a morphogenetic or whole developmental field, particular step
Something is off

65
Q

Describe disruptions - structural changes in dev

A

Teratogens
Casues by interference of an originally normal process. - disrupted
Cannot be inherited, genotype may predispose response of embryo
But genotype not cause of defect

66
Q

Describe an ex of limb deformation - clubfoot

A

Potentially caused by oligohydraminos - low levels of amniotic fluid
Not enough fluid for fetus to move around
Pushed into position, soft = casues bones to bend, can be corrected after birth

67
Q

Describe ex of limb malformation = holt oram syndrome - gen

A

Gene originally linked to 12q21.2-q22
Due to mutation tbx5
Upper limb anomalies, -/+ atrial septal defect in 75%, forelimb affected
Limb anomalies may be limited to thumb or more extensive

68
Q

Describe ex of limb malformation = holt oram syndrome - acc mutations

A

Autosomal dominant disorder with complete penetrance - everyone will have same phenotype, but maybe some variations
Null alleles have more extensive skeletal and cardiac abnormalities - no protein
Missense mutations have moderate phenotypes = protein less functional, so less severe than no protein

69
Q

Give ex of limb disruptions due to thalidomide

A

1956 - used to treat influenza, then as sedeative then to treat nausea vomiting during pregnancy
Classic thalidomide embryopathy = range of defects, depends on dose, include limb anomalies (phocomelia or amelia), congenital heart defects, ear abnormalities, dudodenal atresia, aplasia of thumbs

70
Q

Give ex of limb disruptions due to thalidomide - timing

A

Limb disruptions from thalidomide occurs early during limb dev - tbx5 malformations= major congenital anomalies - weeks 1-8
Limb deformations - club foot = occur later during dev, functional defects and minor anomalies - weeks 9-38

71
Q

Describe summary of limb congenital anomalies

A

Limb malformations can be caused by mutations in signaling molecules (SHH, FGFs and BMPs) or transcription factors (Hox, Tbx).
Limb development is sensitive to teratogens (e.g. thalidomide) that can cause limb disruptions.
Limb deformations (e.g. club foot) occur at later time points during fetal development.

72
Q

What are teratogens

A

Greek origin
Teratos = monster or marvel
Disrupt normal processes
Agent to factor that affects morphogenesis, dev aand differentiation through cell death, failed cell interactions or alterations of cell movements - disrupt many things
Usually applied to environmental causes like drugs, chemicals and viruses
Different teratogens may produce common effects, ex=hot tubs linked to neural tube defects

73
Q

Describe discovery of teratogens - history

A

<1940s = thought embryos were protected from environment by extra embryonic and fetal membranes, thought it was super safe
1941= rubella virus, 1st documented case that an evironental agent could produce disruptions
Silent spring by Rachel Carson 1962, DDT
Thalidomide - summer 1962
Effect of chemicals becomes clear

74
Q

Name the 3 considerations - teratogens

A

Critical periods of development
Dosage of drug/chemical
Genotype of embryo

75
Q

Describe consideration of teratogens = critical periods of dev

A

Early vs late effects - is embryo or fetus sensitive at that time
May extend into postnatal periods = teeth, brain

76
Q

Describe consideration of teratogens = dosage of drug/chemical

A

Dose used in animals if often way&raquo_space; than human exposures, mouse and rats have diff metabolism
Need to establish a dose response curve

77
Q

Describe consideration of teratogens = genotype of embyro

A

Response varies based on genotype of embryo
Like variations of proteins that metabolize the products

78
Q

Describe why/why not drugs are tested on pregnant women

A

In humans, unless a drug is intended to treat a condition unique to pregnancy - studies systematically attempt to exclude women and ensure that women of child bearing age do not become pregnant during period of drug exposure - so no risk
In humans = unethical to conduct trial to assess teratogenicity
Oh 172 fda approved drugs between 2000 and 2010 = 97.7% majority had an undetermined teratogen risk in human pregnancy
73.3% had no data available -regarding safety in pregnancy

79
Q

Name main exs of known teratogens

A

Drugs = alcohol (tied to genotype, many diff genotypes and responses), isotretinoin (retinoic acid), thalidomide
Chemicals= endocrine disrupters, like brith control pills, polluted water makes fish change sex
Infections = rubella virus

80
Q

Name all teratogens

A

Drugs = alcohol, androgens, busulfan, cocaine, DES, isotretinoin, lithium carbonate, methotrexate, phenytoin (dilantin), tetracycline, thalidomide, trimethadione, valproic acid, warfarin
Ionizing radiation
Hyperthermia
Chemicals = methyl mercury, PCBs, endocrine disrupters
Infections = cytomegalovirus, herpes simplex virus, human immunodeficiency virus, human parovirus B19, rubella virus, toxoplasma gondii, treponema palladium, varicella virus

81
Q

Describe thalidomide - conclusions

A

Teratogenic effects casued withdrawn from use 1961-1962
Now being used to treat hiv and cancer
Sensitive periof between 27 and 40 days after conception
Maybe damage neural crest cells

82
Q

What become mandatory after thalidomide incident

A

Testing of drugs in pregnant experimental animals

83
Q

What can ethanol do

A

Induce congenital abnormalities
Alcohol is most devastating teratogen with respect to frequency and cost to society
Prevalent, many defects
Neural tube defects = 1st trimester pregnancy
Fetal alcohol syndrome = hAPPENS LATER, period of dev

84
Q

Describe symptoms of fetal alcohol syndrome

A

A baby with fetal alcohol syndrome may have the following symptoms: Poor growth while the baby is in the womb and after birth Decreased muscle tone and poor coordination
Delayed development and problems in three or more major areas:
thinking, speech, movement, or social skills
Heart defects such as ventricular septal defect/atrial septal defects
Characteristic craniofacial features

85
Q

Describe ethanol induced dysmorphology

A

Treated on gestational day 7 =
Embryos lose midline structures and eyes move towards Center
Get proboscis - almost Cyclopia
Animal study

86
Q

Describe FAS - fetal alc syndrome stats

A

Craniofacial structural defects
2001 estimate = 1out of evert 650
Current estimates higher = up to >1%

87
Q

Describe ethanol induced dysmorphology in human babies

A

Phenotypes range from relative mid fetal alcohol syndrome, cognitive effects and affects ability learn to holoprosencephaly = HPE, since nostril TO HPE + CLEFT LIP (V SERIOUS)

88
Q

What does too much vit a do

A

TERATOGENIC
Retinol = morphogen
Effects = very bad, need to be on 2 forms of birth control before can get higher dose retinol = iPLEDGE PROGRAM

89
Q

What can also induce holoprosencephaly

A

Retinoic acid, cylopia = lost central structures

90
Q

Describe congenital anomalies casues by isotretinoin

A

Increased risk of spontaneous abortions
Hydrocephaly (enlargement of the fluid-filled spaces in the brain)
Microcephaly (small head and brain)
Mental retardation
Ear and eye abnormalities
Cleft palate and other craniofacial abnormalities

91
Q

Describe iPLEDGE PROGRAM

A

Roche Pharmaceuticals had shown birth defects in animals. FDA approved Accutane in 1982 with implementation of voluntary risk management to prevent pregnant women from using drug – not successful!

Lammer et al., 1985 followed 59 women who elected to remain pregnant after RA exposure: 12 spontaneous abortions; 21 major observable anomalies

In 2005 FDA started iPLEDGE a MANDATORY risk-management program that all patients, including men, who take isotretinoin, must participate to achieve two goals (2):
To ensure that no pregnant woman starts taking isotretinoin
To ensure that no woman taking isotretinoin becomes pregnant

Must use at least 2 forms of birth control for 1 month before, during and 1 month after [multiple pregnancy tests].

92
Q

DESCRIBE ethical considerations

A

Animal models
Stem cells
Organoids
Impact of research on planetary health
What is next?

93
Q

Describe ethics of embryology - Gen conc

A

7 YEARS AGO = one health WHO ORGANIZATION = integrated, unifying approach to balance and optimize the health of people, animals and the environment. It is particularly important to prevent, predict, detect, and respond to global health threats such as the COVID-19 pandemic.
Could only culture to 14 days = just before gastrulation
On may 4th 2016 = 2 groups recorded that they had sustained human embryos in vitro for 12-13 days
What are responsibilities, when does life begin
Organoids = take induced pluripotent stem cells and grow tissues
Future considerations

94
Q

DEFINE PROGRESS ZONE

A

Progress zone = zone of highly proliferative mesenchyme that fuels limb outgrowth, progresses outwards, underlines ectoderm

95
Q

DEFINE ZONE OF POLARIZING ACTIVITY

A

Zone of polarizing activity (ZPA)= located in posterior mesenchyme of limb bud - important for pattering a-p or limb digit

96
Q

DEFINE APICAL ECTODERMAL RIDGE

A

Apical ectodermal ride (AER)= formed at boundary of dorsal and ventral ectoderm, thickened

ANAT 381 (24 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions